Jefferies Financial Group’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.29M Sell
20,555
-17,074
-45% -$1.19M 0.01% 821
2025
Q4
$2.5M Buy
37,629
+20,417
+119% +$1.32M 0.01% 718
2025
Q3
$1.16M Buy
17,212
+10,075
+141% +$797K 0.01% 817
2025
Q2
$623K Sell
7,137
-13,725
-66% -$1.08M 0.01% 854
2025
Q1
$1.42M Sell
20,862
-12,781
-38% -$1.04M 0.01% 674
2024
Q4
$2.62M Buy
33,643
+10,979
+48% +$813K 0.02% 574
2024
Q3
$1.52M Buy
22,664
+16,598
+274% +$1.36M 0.01% 670
2024
Q2
$688K Sell
6,066
-321
-5% -$40.6K 0.01% 860
2024
Q1
$886K Sell
6,387
-369
-5% -$46.4K 0.01% 859
2023
Q4
$838K Sell
6,756
-53,580
-89% -$5.47M 0.01% 1030
2023
Q3
$5.63M Buy
60,336
+34,065
+130% +$3.84M 0.05% 303
2023
Q2
$3.38M Sell
26,271
-14,149
-35% -$1.71M 0.03% 488
2023
Q1
$4.7M Sell
40,420
-29,962
-43% -$3.35M 0.04% 383
2022
Q4
$7.97M Buy
+70,382
New +$7.73M 0.06% 270

Other funds holding DXCM

Jefferies Financial Group's DXCM Position: Q1 2026 in Review

Jefferies Financial Group reduced its DexCom (DXCM) stake by 45% in Q1 2026, selling an estimated $1.19M and leaving 20,555 shares worth $1.29M. The position accounts for 0.01% of the portfolio, ranked #821.

Jefferies Financial Group first reported a position in DXCM in Q4 2022 and has held it in 14 quarters since. The position peaked at $7.97M in Q4 2022. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Jefferies Financial Group held 20,555 shares of DexCom worth $1.29M as of Q1 2026.
  • Jefferies Financial Group sold 17,074 DexCom shares in Q1 2026, an estimated $1.19M.
  • DexCom made up 0.01% of Jefferies Financial Group's portfolio in Q1 2026, its #821 holding.
  • Jefferies Financial Group first reported a position in DexCom in Q4 2022 and has held it in 14 quarters since.
  • Jefferies Financial Group's DexCom position peaked at $7.97M in Q4 2022.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.